Human-specific CpG "beacons" identify loci associated with human-specific traits and disease

Area of Science:

• Genomics
• Epigenetics
• Evolutionary Biology

Background:

• Regulatory changes are hypothesized to distinguish human phenotypes from primates.
• CpG dinucleotides and DNA methylation are key epigenetic regulatory mechanisms.
• Species-specific CpG patterns may underlie species-specific gene regulation.

Purpose of the Study:

• To investigate the role of CpG dinucleotides in human phenotypic evolution.
• To identify and characterize a novel genomic feature, CpG beacons.
• To explore the association of CpG beacons with human traits and diseases.

Main Methods:

• Comparative genomics across primates to identify species-specific CpG dinucleotides (CpG beacons).
• Analysis of CpG beacon clusters in humans and their association with disease-related genes.
• MeDIP-seq in human, chimpanzee, and macaque to assess methylation changes in CpG islands (CGIs).

Main Results:

• Identified 21 extreme CpG beacon clusters in humans, associated with monogenic developmental and neurological disease genes.
• Demonstrated that CpG beacon-mediated CpG density gain in CGIs correlates with reduced methylation over evolutionary time.
• Highlighted CpG beacons as genomic loci with significant genetic sequence and epigenetic state interaction.

Conclusions:

• CpG beacons represent a distinct genomic feature influencing CGI evolution and human traits.
• CpG beacons play a role in the regulatory divergence of human phenotype.
• These findings provide insights into the interplay of genetics and epigenetics in evolution and disease.